Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Thinca, The Current Fiscal Year's Net Income Turns to Loss
149A Thinca Co.,Ltd. 【J-GAAP】
Earnings ReportThinca Co.,Ltd. <149A> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The net income (non-consolidated) for the fiscal year ended December 2025 increased by 2.6 times that of the previous period to 42 million yen. For the fiscal year ending December 2026, the net income/loss is expected to turn into a loss of 546 million yen.
In the most recent three-month period, from October to December (4Q), the net income/loss turned to a loss of 4 million yen (compared to a profit of 3 million yen in the same period last year). The operating profit margin drastically worsened from 7.1% in the same period last year to 0.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 1,040 | 101 | 98 | 108 | 40.5 | 0 | Mar 27, 2024 | J-GAAP |
| Dec, 2024 | 1,232 | 78 | 48 | 16 | 5.3 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 1,464 | 60 | 62 | 42 | 13.5 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +18.8% | -23.1% | +29.2% | +162.5% | +155.8% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 1,479 | 50 | 49 | 24 | 7.5 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 Results | 1,464 | 60 | 62 | 42 | 13.5 | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | -1.0% | +20.0% | +26.5% | +75.0% | +80.0% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 702 | 36 | 36 | 27 | 8.6 | 0 | Aug 14, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 1,232 | 78 | 48 | 16 | 5.3 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 1,464 | 60 | 62 | 42 | 13.5 | 0 | Feb 13, 2026 | J-GAAP |
| Dec, 2026 Guidance | 1,858 | -579 | -580 | -546 | -170.3 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +26.9% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 336 | 24 | 23 | 3 | 1.0 | 7.1 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 341 | 11 | 11 | 7 | 2.3 | 3.2 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 361 | 25 | 25 | 20 | 6.4 | 6.9 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 367 | 22 | 23 | 19 | 6.0 | 6.0 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 395 | 2 | 3 | -4 | -1.3 | 0.5 | Feb 13, 2026 | J-GAAP |
| YoY | +17.6% | -91.7% | -87.0% | - | - |
Related Articles
Kubota Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
eGuarantee, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Increases by 3%
Cuorips, Ordinary Profit Forecast for the Fiscal Year Loss Widened in Downward Revision
Nxera Pharma, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
MEEQ, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 63%, Oct-Dec Ordinary Profit Increases by 2.1 times
OPTORUN, 2.3 times Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 Yen
NOVARESE, 89% Increase in Net Income for the Last Fiscal Year, Current period performance is undisclosed.
EYEZ INC, Ordinary Profit/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
WILSON LEARNING WORLDWIDE, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Loss Narrows
Excite Holdings, Apr-Dec (Cumulative 3Q) Net Income Decreases by 92%